510(k) Report

510(k) · Cleared

Cleared

Quicktome

K203518510(k) TraditionalCleared Mar 9, 202198-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Omniscient Neurotechnology Pty Ltd (O8t) · LLZ System, Image Processing, Radiological

Cleared on Mar 9, 2021 as substantially equivalent to K081512 (Medtronic Navigation, Inc., 2008) after a 98-day review. Its family tree reaches back 1 generation to 2008. 4 later devices descend from it.

Decided
Mar 9, 2021
Review
98 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K081512 (2008). 4 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2024: 1 descendant cleared2023: 1 descendant cleared2025: 1 descendant cleared2026: 1 descendant clearedReference device: K113732 · Iplan (Iplan Cranial, Iplan Stereotaxy, Iplan Ent, Iplan CMF, Iplan View, Iplan Spine) · Brainlab AG · 2012K081512 · Stealthviz Advanced Planning Application with Stealthdti Package · Medtronic Navigation, Inc. · 200820052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 1 descendant3 generations forward: 1 descendant K081512 · Stealthviz Advanced Planning Application with Stealthdti Package · Medtronic Navigation, Inc. · 20080
  1. Root · 1 generation backK081512 Stealthviz Advanced Planning Application with Stealthdti PackageMedtronic Navigation, Inc. · 2008
  2. This deviceK203518 QuicktomeOmniscient Neurotechnology Pty Ltd (O8t) · 2021
  3. Descendant · cites it directly · 2 of its ownK230913 ANDIImeka Solutions, Inc. · 2023
  4. Descendant · 2 generations on · 1 of its ownK252298 ANDI 2.0Imeka Solutions, Inc. · 2025
  5. Descendant · 3 generations on · 0 of its ownK261405 ANDI 2.2Imeka Solutions, Inc. · 2026
  6. Descendant · cites it directly · 0 of its ownK243209 nordicMEDiVANordicneurolab AS · 2024

Most influential descendants

Showing 4 of 4 · See all
  • K230913ANDIImeka Solutions, Inc. · 2023 · cites it directly2descendants
  • K252298ANDI 2.0Imeka Solutions, Inc. · 2025 · 2 generations on1descendant
  • K261405ANDI 2.2Imeka Solutions, Inc. · 2026 · 3 generations on0descendants
  • K243209nordicMEDiVANordicneurolab AS · 2024 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K081512Stealthviz Advanced Planning Application with Stealthdti PackageMedtronic Navigation, Inc.2008—
0 (this device)K203518QuicktomeOmniscient Neurotechnology Pty Ltd (O8t)2021—
+1K230913ANDIImeka Solutions, Inc.2023—
+2K252298ANDI 2.0Imeka Solutions, Inc.2025—
+3K261405ANDI 2.2Imeka Solutions, Inc.2026—
+1K243209nordicMEDiVANordicneurolab AS2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
202410
202510
202610
FIG. 1 — Lineage of K203518, 2008–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K081512Stealthviz Advanced Planning Application with Stealthdti Package
Summary page 4
…92.2050) Regulatory Class: Class II Product Code: LLZ 5.3 Predicate Device StealthViz Advanced Planning Application with StealthDTI Package, K081512 This Predicate has not been subject to a design-related recall. Reference Device: iPlan Cranial, K113732 5.4 Device Description…
Medtronic Navigation, Inc.2008—
†K113732Iplan (Iplan Cranial, Iplan Stereotaxy, Iplan Ent, Iplan CMF, Iplan View, Iplan Spine)Brainlab AG2012—

Also cleared against K081512: 3 other devices →

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K230913ANDIImeka Solutions, Inc.20232
K243209nordicMEDiVANordicneurolab AS20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K230913 (Imeka Solutions, Inc., 2023) has gone furthest, with 2 descendants of its own.
  • 3 other devices also cite its predicate K081512.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

Quicktome is intended for display of medical images and other healthcare data. It includes functions for image review, image manipulation, basic measurements, planning, and 3D visualization (MPR reconstructions and 3D volume rendering). Modules are available for image processing and atlas-assisted visualization and segmentation, where an output can be generated for use by a system capable of reading DICOM image sets. Quicktome is indicated for use in the…

Read the full statement (100 words)

Quicktome is intended for display of medical images and other healthcare data. It includes functions for image review, image manipulation, basic measurements, planning, and 3D visualization (MPR reconstructions and 3D volume rendering). Modules are available for image processing and atlas-assisted visualization and segmentation, where an output can be generated for use by a system capable of reading DICOM image sets.

Quicktome is indicated for use in the processing of diffusion-weighted MRI sequences into 3D maps that represent white-matter tracts based on constrained spherical deconvolution methods.

Typical users of Quicktome are medical professionals, including but not limited to surgeons and radiologists.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K203518: Quicktome.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K203518

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026